Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction

Clinical Biochemistry

Volumn 45, Issue 10-11, 2012, Pages 727-732

  Li, Chuanwei ^a,b   Pei, Fang ^a,b   Zhu, Xiaoshan ^c   Duan, Dayue D ^b,c   Zeng, Chunyu ^a,b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b Chongqing Institute of Cardiology   (China)

^c UNIVERSITY OF NEVADA   (United States)

Author keywords

Acute myocardial infarction; Biomarker; Circulating; MicroRNA

Indexed keywords

MICRORNA; MICRORNA 1; MICRORNA 1291; MICRORNA 133; MICRORNA 208; MICRORNA 499; MICRORNA 663B; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; BIOGENESIS; EXOSOME; GENE EXPRESSION; HUMAN; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; MICRORNAS; MYOCARDIAL INFARCTION; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 84862583782     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.04.013     Document Type: Review

References (77)

1. He J., Gu D., Wu X., Reynolds K., Duan X., Yao C., et al. Major causes of death among men and women in China. N Engl J Med 2005, 353:1124-1134.
2. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
3. Yeh R.W., Sidney S., Chandra M., Sorel M., Selby J.V., Go A.S. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2010, 362:2155-2165.
4. Van de Werf F., Bax J., Betriu A., Blomstrom-Lundqvist C., Crea F., Falk V., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008, 29:2909-2945.
5. Moe K.T., Wong P. Current trends in diagnostic biomarkers of acute coronary syndrome. Ann Acad Med Singapore 2010, 39:210-215.
6. Chan D., Ng L.L. Biomarkers in acute myocardial infarction. BMC Med 2010, 8:34.
7. Iribarren C., Phelps B.H., Darbinian J.A., McCluskey E.R., Quesenberry C.P., Hytopoulos E., et al. Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study. BMC Cardiovasc Disord 2011, 11:31.
8. Kroh E.M., Parkin R.K., Mitchell P.S., Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010, 50:298-301.
9. Fichtlscherer S., Rosa S.D., Fox H., Schwietz T., Fischer A., Liebetrau C., et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107:677-684.
10. Wang R., Li N., Zhang Y., Ran Y., Pu J. Circulating microRNAs are promising novel biomarkers of acute myocardial infarction. Intern Med 2011, 50:1789-1795.
11. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
12. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function genomics: the miRNA genes. Cell 2004, 116:281-297.
13. Bentwich I., Avniel A., Karov Y., Aharonov R., Gilad S., Barad O., et al. Identification of hundreds of conserved and non conserved human microRNAs. Nat Genet 2005, 37:766-770.
14. Griffiths-Jones S., Saini H.K., van Dongen S., Enright A.J. MiRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36:D154-D158.
15. Kozomara A., Griffiths-Jones S. MiRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011, 39:D152-D157.
16. Gschwend A.R., Weingartner L.A., Moore R.C., Ming R. The sex-specific region of sex chromosomes in animals and plants. Chromosome Res 2012, 20:57-69.
17. Yin Z., Li C., Han X., Shen F. Identification of conserved microRNAs and their target genes in tomato (Lycopersicon esculentum). Gene 2008, 414:60-66.
18. Dhandapani V., Ramchiary N., Paul P., Kim J., Choi S.H., Lee J., et al. Identification of potential microRNAs and their targets in Brassica rapa L. Mol Cells 2011, 32:21-37.
19. Sibley C.R., Seow Y., Saayman S., Dijkstra K.K., El Andaloussi S., Weinberg M.S., et al. The biogenesis and characterization of mammalian microRNAs of mirtron origin. Nucleic Acids Res 2012, 40:438-448.
20. Starega-Roslan J., Koscianska E., Kozlowski P., Krzyzosiak W.J. The role of the precursor structure in the biogenesis of microRNA. Cell Mol Life Sci 2011, 68:2859-2871.
21. Han J., Lee Y., Yeom K.H., Kim Y.K., Jin H., Kim V.N. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev 2004, 18:3016-3027.
22. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003, 17:3011-3016.
23. Wang X., Xu X., Ma Z., Huo Y., Xiao Z., Li Y., et al. Dynamic mechanisms for pre-miRNA binding and export by Exportin-5. RNA 2011, 17:1511-1528.
24. Madina B.R., Kuppan G., Vashisht A.A., Liang Y.H., Downey K.M., Wohlschlegel J.A., et al. Guide RNA biogenesis involves a novel RNase III family endoribonuclease in Trypanosoma brucei. RNA 2011, 17:1821-1830.
25. Park J.E., Hel I., Tian Y., Simanshu D.K., Chang H., Jee D., et al. Dicer recognizes the 5' end of RNA for efficient and accurate processing. Nature 2011, 475:201-205.
26. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 12:15-20.
27. Ambros V., Bartel B., Bartel D.P., Burge C.B., Carrington J.C., Chen X., et al. A uniform system for microRNA annotation. RNA 2003, 9:277-279.
28. 2-induced injury on cardiac myocytes via its target gene PDCD4. J Mol Cell Cardiol 2009, 47:5-14.
29. Wu C.D., Kuo Y.S., Wu H.C., Lin C.T. Microrna-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells. J Biomed Sci 2011, 18:80.
30. El Gazzar M., Church A., Liu T., McCall C.E. Microrna-146a regulates both transcription silencing and translation disruption of TNF-a during TLR4-induced gene reprogramming. J Leukoc Biol 2011, 90:509-519.
31. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006.
32. Turchinovich A., Weiz L., Langheinz A., Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011, 39:7223-7233.
33. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011, 108:5003-5008.
34. Wang K., Zhang S., Weber J., Baxter D., Galas D.J. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 2010, 38:7248-7259.
35. Kennedy M.A., Barrera G.C., Nakamura K., Baldán Á., Tarr P., Fishbein M.C., et al. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation. Cell Metab 2005, 1:121-131.
36. Zhang Y., Zanotti I., Reilly M.P., Glick J.M., Rothblat G.H., Rader D.J. Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo. Circulation 2003, 108:661-663.
37. Vickers K.C., Palmisano B.T., Shoucri B.M., Shamburek R.D., Remaley A.T. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011, 13:423-433.
38. Skog J., Wurdinger T., van Rijn S., Meijer D.H., Gainche L., Sena-Esteves M., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10:1470-1476.
39. Hunter M.P., Ismail N., Zhang X., Aguda B.D., Lee E.J., Yu L., et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008, 3:e3694.
40. Ratajczak J., Wysoczynski M., Hayek F., Janowska-Wieczorek A., Ratajczak M.Z. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20:1487-1495.
41. Kosaka N., Iguchi H., Yoshioka Y., Takeshita F., Matsuki Y., Ochiya T. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 2010, 285:17442-17452.
42. Camussi G., Deregibus M.C., Bruno S., Cantaluppi V., Biancone L. Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int 2010, 78:838-848.
43. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007, 9:654-659.
44. Wang Z., Luo X., Lu Y., Yang B. MiRNAs at the heart of the matter. J Mol Med (Berl) 2008, 86:771-783.
45. Chinchilla A., Lozano E., Daimi H., Esteban F.J., Crist C., Aranega A.E., et al. MicroRNA profiling during mouse ventricular maturation: a role for miR-27 modulating Mef2c expression. Cardiovasc Res 2011, 89:98-108.
46. Shen E., Diao X., Wei C., Wu Z., Zhang L., Hu B. MicroRNAs target gene and signaling pathway by bioinformatics analysis in the cardiac hypertrophy. Biochem Biophys Res Commun 2010, 397:380-385.
47. Fukushima Y., Nakanishi M., Nonogi H., Goto Y., Iwai N. Micro-managing myocyte mitosis. Circ Res 2011, 109:611-613.
48. Bauersachs J., Thum T. Biogenesis and regulation of cardiovascular microRNAs. Circ Res 2011, 109:334-347.
49. Hartmann D., Thum T. MicroRNAs and vascular (dys)function. Vascul Pharmacol 2011, 55:92-105.
50. Di Stefano V., Zaccagnini G., Capogrossi M.C., Martelli F. microRNAs as peripheral blood biomarkers of cardiovascular disease. Vascul Pharmacol 2011, 55:111-118.
51. Hoekstra M., van der Lans C.A., Halvorsen B., Gullestad L., Kuiper J., Aukrust P. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 2010, 394:792-797.
52. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010, 107:677-684.
53. Hoekstra M., van der Lans C.A., Halvorsen B., Gullestad L., Kuiper J., Aukrust P., et al. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun 2010, 394:792-797.
54. Wang G.K., Zhu J.Q., Zhang J.T., Li Q., Li Y., He J., et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010, 31:659-666.
55. D'Alessandra Y., Devanna P., Limana F., Straino S., Di Carlo A., Brambilla P.G., et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010, 31:2765-2773.
56. Kuwabara Y., Ono K., Horie T., Nishi H., Nagao K., Kinoshita M., et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 2011, 4:446-454.
57. Gidlöf O., Andersson P., van der Pals J., Götberg M., Erlinge D. CardiospecificmicroRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 2011, 118:217-226.
58. De Rosa S., Fichtlscherer S., Lehmann R., Assmus B., Dimmeler S., Zeiher A.M. Transcoronary concentration gradients of circulating microRNAs. Circulation 2011, 124:1936-1944.
59. Yang B., Lin H., Xiao J., Lu Y., Luo X., Li B., et al. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 2007, 13:486-491.
60. Xu C., Lu Y., Pan Z., Chu W., Luo X., Lin H., et al. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. J Cell Sci 2007, 120:3045-3052.
61. Cheng Y., Tan N., Yang J., Liu X., Cao X., He P., et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond) 2010, 119:87-95.
62. Ai J., Zhang R., Li Y., Pu J., Lu Y., Jiao J., et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010, 391:73-77.
63. Han M., Toli J., Abdellatif M. MicroRNAs in the cardiovascular system. Curr Opin Cardiol 2011, 26:181-189.
64. Torella D., Iaconetti C., Catalucci D., Ellison G.M., Leone A., Waring C.D., et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 2011, 109:880-893.
65. Widera C., Gupta S.K., Lorenzen J.M., Bang C., Bauersachs J., Bethmann K., et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol 2011, 51:872-875.
66. Freda B.J., Tang W.H., Van Lente F., Peacock W.F., Francis G.S. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 2002, 40:2065-2071.
67. Korkmaz H., Saşak G., Celik A., Kurtoǧlu E., Gürger M., Bursali K.B., et al. The comparison of cardiac biomarkers positivities in hemodialysis patients without acute coronary syndrome. Ren Fail 2011, 33:578-581.
68. van Rooij E., Sutherland L.B., Qi X., Richardson J.A., Hill J., Olson E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316:575-579.
69. Callis T.E., Pandya K., Seok H.Y., Tang R.H., Tatsuguchi M., Huang Z.P., et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009, 119:2772-2786.
70. Adachi T., Nakanishi M., Otsuka Y., Nishimura K., Hirokawa G., Goto Y., et al. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clin Chem 2010, 56:1183-1185.
71. Shieh J.T., Huang Y., Gilmore J., Srivastava D. Elevated miR-499 levels blunt the cardiac stress response. PLoS One 2011, 6:e19481.
72. Meder B., Keller A., Vogel B., Haas J., Sedaghat-Hamedani F., Kayvanpour E., et al. MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol 2011, 106:13-23.
73. Kim H.C., Greenland P., Rossouw J.E., Manson J.E., Cochrane B.B., Lasser N.L., et al. Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. J Am Coll Cardiol 2010, 55:2080-2091.
74. Pencina M.J., D'Agostino R.B., D'Agostino R.B., Vasan R.S. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008, 27:157-172.
75. Duttagupta R., Jiang R., Gollub J., Getts R.C., Jones K.W. Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One 2011, 6:e20769.
76. McDonald J.S., Milosevic D., Reddi H.V., Grebe S.K., Algeciras-Schimnich A. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem 2011, 57:833-840.
77. Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernandez-Aviles F., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007, 28:1598-1660.